Site-specific reactivity of stepped Pt surfaces driven by stress release.
Guangdong LiuArthur J ShihHuiqiu DengKasinath OjhaXiaoting ChenMingchuan LuoIan T McCrumMarc T M KoperJeffrey P GreeleyZhenhua ZengPublished in: Nature (2024)
Heterogeneous catalysts are widely used to promote chemical reactions. Although it is known that chemical reactions usually happen on catalyst surfaces, only specific surface sites have high catalytic activity. Thus, identifying active sites and maximizing their presence lies at the heart of catalysis research 1-4 , in which the classic model is to categorize active sites in terms of distinct surface motifs, such as terraces and steps 1,5-10 . However, such a simple categorization often leads to orders of magnitude errors in catalyst activity predictions and qualitative uncertainties of active sites 7,8,11,12 , thus limiting opportunities for catalyst design. Here, using stepped Pt(111) surfaces and the electrochemical oxygen reduction reaction (ORR) as examples, we demonstrate that the root cause of larger errors and uncertainties is a simplified categorization that overlooks atomic site-specific reactivity driven by surface stress release. Specifically, surface stress release at steps introduces inhomogeneous strain fields, with up to 5.5% compression, leading to distinct electronic structures and reactivity for terrace atoms with identical local coordination, and resulting in atomic site-specific enhancement of ORR activity. For the terrace atoms flanking both sides of the step edge, the enhancement is up to 50 times higher than that of the atoms in the middle of the terrace, which permits control of ORR reactivity by either varying terrace widths or controlling external stress. Thus, the discovery of the above synergy provides a new perspective for both fundamental understanding of catalytically active atomic sites and design principles of heterogeneous catalysts.
Keyphrases
- highly efficient
- ionic liquid
- metal organic framework
- room temperature
- stress induced
- reduced graphene oxide
- heart failure
- gold nanoparticles
- patient safety
- randomized controlled trial
- systematic review
- visible light
- carbon dioxide
- high throughput
- escherichia coli
- mass spectrometry
- electron microscopy
- adverse drug
- staphylococcus aureus